1 Ren J,Peng Z,Yang K.A clinicopathologic multivariate analysis affecting recurrence of borderline ovarian tumors.Gynecol Oncol,2008,110:162-167.
2 T rnovanu MC,Amancei S,Dumitrescu A,et al.Management of borderline ovarian tumors.2013,116:1069-1075.
3 Wang WZ,Liu XY,Yue Y,et al.Advances in diagnosis and treatment of borderline ovarian tumors.China's Maternity and Child Care,2011,26:1747-1748.
4 Liu LK,Xu J,Yang SQ,et al.Clinical analysis of 23 cases in borderline ovarian tumors.Practical Clinical Medicine,2013,14:73-74.
5 Tian M, Yang T, Min HE.Value of Contrast-Enhanced Ultrasound in the Diagnosis of Ovarian Lesions.J Pract Obstet Gynecol,2011,27:458-460.
6 陈荟竹,王梦甜,等.卵巢恶性肿瘤的影像学诊断进展.中华妇幼临床医学杂志(电子版),2015,11:90-94.
7 Kitajima K,Suzuki K,Senda M ,et al.FDG-PET/CT for diagnosis of primary ovarian cancer.Nucl Med Commun,2011,32:549-553.
8 Kitajima K,Murakami K,Sakamoto S,et al.Present and future of FDG-PET/CT in ovarian cancer.Ann Nucl Med,2011,25:155-164.
9 Antunovic L,Cimitan M,Borsatti E,et al.Revisiting the clinical value of 18F-FDG PET/CT in detection of recurrent epithelial ovarian carcinomas.Clin Nucl Med,2012,37:e184-e188.
10 Gotlieb WH,Sorino D,Achiron R,et al.CA125 measurement and ultrasonography in borderling tumors of the ovary.Am J Obstet Gynecol,2000,183:541-546.
11 Alanbay I,Akturk E,Coksuer H,et al.Comparison of risk of malignancy index (RMI),CA125,CA 19-9,ultrasound score,and menopausal status in borderline ovarian tumor.Gynecol Endocrinol,2012,28:478-482.
12 梁旭东,曾浩霞,李艺,等.卵巢交界性上皮性肿瘤临床分析.中国妇产科临床杂志,2010,11:406-409.
13 刘娅,杨兴升,刘培淑,等.92例卵巢交界性肿瘤患者的临床病例分析.山东大学,2015.
14 Tropé CG,Kaern J,Davidson B,et al.Borderline ovarian tumors.Best Practice & Research Clin Obstet Gynecol,2012,26:325-336.
15 Leeuwen FEV,Klip HWA J,Mooij TM,et al.Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort.Hum Reprod,2011,26:3456-3465.
16 Song T.Oncologic and reproductive outcomes of cystectomy compared with oophorectomy as treatment for borderline ovarian tumor.Gynecol Oncol,2011,26:2008-2014.
17 Tsai HW,Ko CC,Yeh CC,et al.Unilateral salpingo-oophorectomy as fertility-sparing surgery for borderline ovarian tumors.J Chin Med Assoc,2011,74:250-254.
18 Tsui KH,Wang PH.Borderline ovarian tumor and future fertility.J Chin Med Assoc,2011,74:241-242.
19 Cho JE,Liu C,Gossner G,et al.Laparoscopy and gynecologic oncology.Clin Obstet Gynecol,2009,52:313-326.
20 李华,洛若愚.手术联合化疗治疗交界性卵巢肿瘤的临床研究.疑难病杂志,2013,12:287-289.
21 Leary A,Petrella MC,Pautier P,et al.Adjuvant platinum-based chemotherapy for borderline serous ovarian tumors with invasive implants.Gynecol Oncol,2014,132:23-27.
22 Trimble CL,Kosary C,Trimble EL.Long-Term Survival and Patterns of Care in Women with Ovarian Tumors of Low Malignant Potential.Gynecol Oncol,2002,86:34-37.
23 Nam JH.Borderline ovarian tumors and fertility.Curr Opin Obstet Gyn,2010,22:69-72.
24 李艺,崔恒.卵巢交界性肿瘤术后生育时机妊娠率及分娩后处理.中国实用妇科于产科杂志.2015,31:999-1001.
25 Fortin A,Morice P,Thoury A,et al.Impact of infertility drugs after treatment of borderline ovarian tumors:results of a retrospective multicenter study.Fteril Steril,2007,87:591-596.
26 Mahdavi A,Pejovic T,Nezhat F,et al.Induction of ovulation and ovarian cancer:a critical review of the literature.Fteril Steril,2006,85:819-826.
27 李珺玮,华克勤.妊娠合并卵巢恶性肿瘤的诊疗进展.现代妇产科进展,2013,22:322-324.
28 Ferrandina G,Distenafo M,Testa A,et al.Management of advanced ovarian cancer at 15 weeks of gestation:case report and literature review.Gynecol Oncol,2005,97:693-696.
